10,11-dihydrocarbamazepine,
dihydrocarbamazepine,
10,11-Dihydrocarbamazepine,
3564-73-6,
10,11-Dihydro-5H-dibenzo[b,f]azepine-5-carboxamide,
Dihydrocarbamazepine,
UNII-EC017VA9FR,
GP 26-301,
5H-Dibenz[b,f]azepine-5-carboxamide, 10,11-dihydro-,
EINECS 222-649-0,
BRN 0196969,
EC017VA9FR,
CHEMBL41543,
5,6-Dihydrobenzo[b][1]benzazepine-11-carboxamide,
10,11-Dihydro-5H-dibenz[b,f]azepine-5-carboxamide,
MFCD00005072,
AK146901,
5H-DIBENZ(b,f)AZEPINE-5-CARBOXAMIDE, 10,11-DIHYDRO-,
10,11-Dihydro-5H-dibenz(b,f)azepine-5-carboxamide,
AC1L2DGI,
Oprea1_404143,
4-20-00-03905 (Beilstein Handbook Reference),
10,11-Dihydro Carbamazepine,
10,11-Dihydro-carbamazepine,
SCHEMBL1744688,
DTXSID90189151,
PHNLCHMJDSSPDQ-UHFFFAOYSA-N,
10,11-Dihydrocarbamazepine, 99%,
BCP08934,
ZINC3008650,
BDBM50446087,
STL450943,
AKOS000577095,
ACM3564736,
MCULE-5197094540,
KS-00000S57,
AJ-44338,
AN-16613,
LS-60363,
SC-82443,
ST044503,
AX8284430,
10H,11H-dibenzo[b,f]azepine-5-carboxamide,
EU-0076522,
FT-0607181,
ST24038218,
10,11-Dihydrocarbamazepine, analytical standard,
SR-01000312724,
SR-01000312724-1,
Dibenzo[b,f]azepine, 10,11(5H)-dihydro-5-carbamyl-,
I14-46983,
10,11-Dihydro-5H-dibenzo[b,f]azepine-5-carboxamide #,
Carbamazepine impurity A, European Pharmacopoeia (EP) Reference Standard,
10,11-Dihydro-5H-dibenzo[b,f]-azepine-5-carboxamide (10,11-Dihydro-carbamazepine),
Carbamazepine Related Compound A, United States Pharmacopeia (USP) Reference Standard,
10,11-Dihydrocarbamazepine(Carbamazepine Related Compound A), Pharmaceutical Secondary Standard; Certified Reference Material,
carbamazepine,
Trimeproprimin,
Amizepin,
C15H14N2O,
CID19099,
C15-H14-N2-O,
298-46-4,